Phase
Condition
Inflammation
Treatment
N/AClinical Study ID
Ages 5-6 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Non-regular milk drinker;
Suffered from mild to moderate milk intolerance;
Agree not to take any medication, supplements, nutrition or other dairy productsincluding acidophilus milk;
Parent(s) or legal guardian's consent to the study and willing to comply with studyprocedures;
Parent(s) or guardian of infant agrees not to enroll infant another clinical studywhile participating in this study;
Fully understand the nature, objective, benefit and the potential risks and sideeffects of the study.
Exclusion
Exclusion Criteria:
Have known dairy allergy;
Suffered from severe milk intolerance;
Unable to give written informed consent;
Use of antibiotics at the time of screening, or during the past two weeks;
Have history of fecal impaction;
Trying to lose weight by following a diet or exercise regimen designed for weightloss, or taking any drug influencing appetite and any drug for weight loss for thelast three months;
Have participated in similar dairy or probiotics-containing product's clinical trialswithin 3 months before the screening;
Currently taking medicines for cardiovascular or metabolic disease;
Have history of or be diagnosed of any of the following diseases that may affect thestudy results: gastrointestinal disorders, hepatopathy, nephropathy, endocrinedisease, blood disorders, respiratory and cardiovascular diseases;
Currently suffering from any gastrointestinal disorders or gastrointestinal disease ,including but not limited to: irritable bowel syndrome, colitis, ulcerative colitis,celiac disease, irritable bowel syndrome (IBS);
Had hospitalizations within 3 months before screening;
According to investigator's judgment, current frequent users of drugs may affect thegastrointestinal function or immune system.